GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 289 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,000 | -91.8% | 72 | -95.8% | 0.00% | -100.0% |
| Q4 2020 | $196,000 | +18.8% | 1,697 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $165,000 | -20.7% | 1,697 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $208,000 | +39.6% | 1,697 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $149,000 | -17.2% | 1,697 | -1.7% | 0.00% | 0.0% |
| Q4 2019 | $180,000 | -11.8% | 1,726 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $204,000 | -33.1% | 1,771 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $305,000 | +2.0% | 1,771 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $299,000 | +89.2% | 1,771 | +9.0% | 0.00% | +100.0% |
| Q4 2018 | $158,000 | -43.8% | 1,625 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $281,000 | +284.9% | 1,625 | +193.9% | 0.00% | – |
| Q4 2017 | $73,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |